Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, ...
On April 22, 2026, CervoMed reported Phase 2b RewinD-LB trial data presented at the American Academy of Neurology meeting showing that neflamapimod increased basal forebrain volume and enhanced ...
This image represents the opposite effects the basal forebrain has on feeding behavior. It either induces obesity or anorexia depending on the level of activity. If the basal forebrain is inactive, ...
Update will include new MRI analyses from the Phase 2b RewinD-LB clinical trial, status of global regulatory discussions, and finalized Phase 3 trial design Additional data from MRI analyses will also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results